Literature DB >> 33640014

Standard exercise stress testing attenuates peripheral microvascular function in patients with suspected coronary microvascular dysfunction.

Massimo Nardone1, Steven Miner1,2, Mary McCarthy2, Heather Edgell3,4.   

Abstract

BACKGROUND: The effect of exercise on the microvasculature of patients with suspected coronary microvascular dysfunction (CMD), assessed by reactive hyperemia peripheral arterial tonometry (RH-PAT; EndoPAT), is unknown. The present study aimed to determine if standard clinical exercise stress testing (GXT) affected peripheral microvascular function, as determined by the reactive hyperemia index (RHI and LnRHI), in patients with suspected CMD.
METHODS: In a cross-sectional study, patients (n = 76) were grouped based on whether the GXT was performed; 1) prior to (exercisers; n = 30), or 2) after the vascular assessment (non-exercisers; n = 46). Patients with an adenosine index of microvascular resistance > 25, adenosine coronary flow reserve (CFR) < 2.0, and/or acetylcholine CFR < 1.5 were considered to have CMD (n = 42). RHI and LnRHI quantified finger pulse amplitude hyperemia following 5 min of forearm ischemia.
RESULTS: LnRHI was lower in patients with CMD compared to patients without CMD, while LnRHI was also lower in exercisers compared to non-exercisers (LnRHI: CMD Non-Exercisers: 0.63 ± 0.25; CMD Exercisers: 0.54 ± 0.19; No CMD Non-Exercisers: 0.85 ± 0.23; No CMD Exercisers: 0.63 ± 0.26; Condition and Exercise Main Effects: Both P < 0.01). In patients who did not exercise prior to the vascular assessment, the receiver operating characteristic curve (ROC) for LnRHI to predict CMD was 0.76 (95% CI: 0.62-0.91; P < 0.01). However, in patients who performed exercise prior to the vascular assessment, the ROC for LnRHI to predict CMD was 0.60 (95% CI: 0.40-0.81; P = 0.34).
CONCLUSIONS: CMD is associated with impaired peripheral microvascular function and preceding acute exercise is associated with further reductions of LnRHI. Further, acute exercise abolished the capacity for RH-PAT to predict the presence of CMD in patients with chest pain and non-obstructive coronary arteries. RH-PAT measurements in patients with suspected CMD should not be conducted after exercise has been performed.

Entities:  

Keywords:  Acute exercise; Augmentation index; EndoPAT; Microvascular; Peripheral arterial tonometry; Reactive hyperemia

Year:  2021        PMID: 33640014      PMCID: PMC7913424          DOI: 10.1186/s13102-021-00246-8

Source DB:  PubMed          Journal:  BMC Sports Sci Med Rehabil        ISSN: 2052-1847


  44 in total

1.  Noninvasive Microvascular Indices Reveal Peripheral Vascular Abnormalities in Patients With Suspected Coronary Microvascular Dysfunction.

Authors:  Massimo Nardone; Steven Miner; Mary McCarthy; Chris I Ardern; Heather Edgell
Journal:  Can J Cardiol       Date:  2019-12-10       Impact factor: 5.223

Review 2.  Reliable endothelial function testing: at our fingertips?

Authors:  David S Celermajer
Journal:  Circulation       Date:  2008-05-13       Impact factor: 29.690

3.  Peripheral microvascular dysfunction predicts residual risk in coronary artery disease patients on statin therapy.

Authors:  Yuya Matsue; Kazuki Yoshida; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Akihiko Matsumura; Yuji Hashimoto; Masayuki Yoshida
Journal:  Atherosclerosis       Date:  2013-11-20       Impact factor: 5.162

4.  Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?

Authors:  F L Sax; R O Cannon; C Hanson; S E Epstein
Journal:  N Engl J Med       Date:  1987-11-26       Impact factor: 91.245

Review 5.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

6.  Relation between peripheral vascular endothelial function and coronary flow reserve in patients with chest pain and normal coronary angiogram.

Authors:  Chul-Soo Park; Ho-Joong Youn; Ji-Hoon Kim; Eun-Joo Cho; Hae-Ok Jung; Hui-Kyung Jeon; Jong-Min Lee; Sang-Hyun Ihm; Yong-Seog Oh; Wook-Sung Chung; Jae-Hyung Kim; Kyu-Bo Choi; Soon-Jo Hong
Journal:  Int J Cardiol       Date:  2005-11-28       Impact factor: 4.164

Review 7.  Assessment of endothelial function using digital pulse amplitude tonometry.

Authors:  Naomi M Hamburg; Emelia J Benjamin
Journal:  Trends Cardiovasc Med       Date:  2009-01       Impact factor: 6.677

Review 8.  Coronary microvascular dysfunction.

Authors:  Paolo G Camici; Filippo Crea
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

9.  Peripheral endothelial function and cardiovascular events in high-risk patients.

Authors:  Yasushi Matsuzawa; Seigo Sugiyama; Hitoshi Sumida; Koichi Sugamura; Toshimitsu Nozaki; Keisuke Ohba; Junichi Matsubara; Hirofumi Kurokawa; Koichiro Fujisue; Masaaki Konishi; Eiichi Akiyama; Hiroyuki Suzuki; Yasuhiro Nagayoshi; Megumi Yamamuro; Kenji Sakamoto; Satomi Iwashita; Hideaki Jinnouchi; Masataka Taguri; Satoshi Morita; Kunihiko Matsui; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

10.  Association of digital vascular function with cardiovascular risk factors: a population study.

Authors:  Tatiana Kuznetsova; Eline Van Vlierberghe; Judita Knez; Gregory Szczesny; Lutgarde Thijs; Dominique Jozeau; Costantino Balestra; Jan D'hooge; Jan A Staessen
Journal:  BMJ Open       Date:  2014-03-24       Impact factor: 2.692

View more
  2 in total

Review 1.  Endothelium in Coronary Macrovascular and Microvascular Diseases.

Authors:  Shigeo Godo; Jun Takahashi; Satoshi Yasuda; Hiroaki Shimokawa
Journal:  J Cardiovasc Pharmacol       Date:  2021-12-03       Impact factor: 3.271

2.  Effect of Upright Posture on Endothelial Function in Women and Men.

Authors:  Karim Habib; Behzad Fallah; Heather Edgell
Journal:  Front Physiol       Date:  2022-03-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.